The Silver Tsunami Is Here — and Precision Surgery Could Be The Biggest Winner Ever
“The graying of America” is happening. By 2030, the entire baby boomer generation (born between 1946 and 1964) will be over 65. During that time, the number of seniors in America will reach a record 73 million. A number of healthcare stocks will benefit from this trend. One in particular Intuitive Surgical (NASDAQ: ISRG). This “silver tsunami” trend should help Intuitive remain a top growth stock.
Here is the way.
Will AI create the world’s first trillionaire? Our team recently released a report on one little-known company, called “Indispensable Monopoly” that provides essential technology needed by both Nvidia and Intel. Continue »
Intuitive Surgical is a medical device technology company. Its flagship product is its da Vinci robotic surgery system. What sets the platform apart is how it makes complex surgeries like prostate removal and colorectal procedures less invasive, reducing the chance of complications and speeding up recovery time.
Competing medical device companies are working to capture a share of this market. However, as the first mover in the space, Intuitive still has about 60% market share. Because of its widespread use, many resident surgeons are learning to perform robotic-assisted surgery on the da Vinci platform. Not surprisingly, Intuitive has maintained its competitive edge.
Operating under the “razor and blades” model, where the company benefits from both the installation of the system and the sale of the equipment used by the system, Intuitive stands to benefit greatly from the increased use driven by the elderly who need various surgeries. As the elderly population increases, the number of surgeries in America is increasing.
Even better, Intuitive is working to expand the customizable platform market. First, its operation is to obtain approval for use in certain surgeries. Second, expand into markets outside the United States. Currently, da Vinci has limited access to overseas markets.
Investors should note that the market is well aware of Intuitive’s growth potential. Shares currently trade at 45 times forward earnings, which is higher than many other medical device stocks. However, if the company continues to grow revenue at a double-digit pace, the shares will likely continue to command a valuation premium, with the stock rising in line with earnings growth.
Before buying stock in Intuitive Surgical, consider the following:
I The Motley Fool Stock Advisor a team of analysts has just identified what they believe to be 10 best stocks for investors to buy now… and Intuitive Surgical was not one of them. The 10 stocks that made the cut could produce huge gains in the coming years.
Think about when Netflix made this list on December 17, 2004… if you invested $1,000 during our recommendation, you will have $573,160!* Whenever Nvidia made this list on April 15, 2005… if you invested $1,000 during our recommendation, you will have $1,204,712!*
Now, it’s worth noting Stock Advisor’s the average total return is 1,002% – outperformed the market by 195% for the S&P 500. Don’t miss the latest top 10 list, available via Stock Advisorand join an investment community built by individual investors for individual investors.
See 10 stocks »
*The Stock Advisor returns as of April 15, 2026.
Thomas Niel has no position in any of the stocks mentioned. The Motley Fool ranks and recommends Intuitive Surgical. The Motley Fool recommends the following options: a long January 2028 $520 call on Intuitive Surgical and a short January 2028 $530 call on Intuitive Surgical. The Motley Fool has a policy of disclosure.
The Silver Tsunami Is Here — and Intuitive Surgical Could Be the Biggest Winner was first published by The Motley Fool.
